In a meeting not too long ago, our head researcher told me that the University wanted the World to know that THE BRAIN that completely challenges the belief that Alzheimer’s is incurable currently resides at the U of MN…
As we all know, Alzheimer’s Disease is a progressive neurologic condition that only worsens with time. No patient on record has ever improved.
That is, before now.
You see, though my dad died of Alzheimer’s, he was able to consistently reverse the hallmark cognitive declines of this disease to the point that his doctors looked to everything OTHER than Alzheimer’s to explain his mysterious condition. A few documented examples of his ability to reverse AD (there are many, many more):
1) He could improve his MoCA test score from 0 – 17 in five days.
2) He could return to walking after needing a wheel chair in three days.
3) He was even able to regain episodic memories, toast champagne and enjoy watching an NFL football game – despite having the most severe AD pathology (level 4).
Not only that, the structure of Dad’s extremely diseased brain was vastly different than what is typically found with end-stage Alzheimer’s. Yes, he had the amount of Amyloid and Tau protein pathology we would expect to see (thus the diagnosis). Yet, Dad’s brain showed only age-appropriate volume loss, and far less structural damage than one would expect to find with this much pathology.
So, what caused Dad’s brain to respond so differently to Alzheimer’s Disease?
The difference was that Dad’s brain received years and years of drug protocols Dad put in place on his own (we are talking FDA approved drugs here). And opposed to all other drugs used to treat Alzheimer’s which have not been found to be effective (1), the drugs Dad took actually helped. In that, when they were discontinued – Dad’s cognition would significantly decline. And when the drugs were restarted – his cognition would significantly improve. In one instance where Dad went from zero-to-hero, Dad was at the point of being mute and requiring a wheel chair – then just 10 days later, he walked independently into the clinic, shook his doc’s hand and said: “Thanks for taking care of me all these years.” That doctor actually missed his stool and fell on the floor in astonishment (and then told me to write a White Paper on Dad’s case). The only difference? Dad’s drug protocols. Unquestionably, it was these drugs that made Dad’s unprecedented cognitive transformations possible and are what allowed Dad to live independently for as long as he did. Remarkably, he was even able to retain spatial orientation and memory all the way up to his death – knowing the direction and distance of Mayo Clinic and recalling his last drive there 5 years prior. There is no instance on record where the entorhinal cortex appeared to be functional at end-stage Alzheimer’s – before now.
Alzheimer’s Disease is unquestionably a pandemic, which is why a research institution like the the U of MN considers it a pretty big deal that Dad chose them to study his brain and associated medication protocols. It’s an even bigger deal when you realize that Universities from all over the world were vying for it as well!
What’s next on the horizon for the infamous “Golden Brain” you ask? Well, for starters, we are working to generate more funding to cover the lab costs associated with testing my dad’s own treatment protocols.
I’m also busy constructing our online resources (website & blog) so that funding partners (and anyone else) have a destination where they can learn more about what we are doing (and learning) at the DEC Legacy Lab. And as an added benefit, I’ll be sharing what the research community is saying about Alzheimer’s risk factors (real and suggested) as well as providing research-based ways you can slow or possibly prevent Alzheimer’s Disease.
Feel free to visit our website at www.CuringAlzheimersDisease.com for more information, and be sure to subscribe to this blog for updates on what is published next.
Citations:
(1) 2020 Current Alzheimer’s drugs do little to help patients https://www.sph.umn.edu/news/current-alzheimers-drugs-do-little-to-help-patients/
About the author: Anna Shelander is a journalist and question-asker who rarely accepts “no” for an answer. Which is why, when her dad (the object of this blog and associated website) became ill with an unexplainable disease, he asked her to come along for the ride. The two worked unsuccessfully within the medical community to find a diagnosis, then branched into the research community where answers finally began to appear. It was at this level of science that Anna and her father began to parse together the drug protocols that dramatically improved his cognition. Unfortunately, the medical community continued to interrupt matters, which is why her dad (DEC) ultimately succumbed to his illness. Fortunately, Anna kept impeccable records so that someday soon DEC’s efforts may yield a Cure for Alzheimer’s Disease.
Copyright © 2022 Curing Alzheimer’s Disease [EIN #88-3154550] All Rights Reserved. This information is not designed to replace a physician’s independent judgment about the appropriateness or risks of a procedure for a given patient. Always consult your doctor about your medical conditions. Curing Alzheimer’s Disease.com does not provide medical advice, diagnosis or treatment. Use of the site is conditional upon your acceptance of our terms of use.
